TickerFacts.

Cardiff Oncology, Inc. (CRDF): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2019-12-31
$1.81M2014-12-31: $15.4K2015-12-31: $629.2K2016-12-31: $1.73M2017-12-31: $1.81M2018-12-31: $597.5K2019-12-31: $0$0
2014-12-31 Cost of Revenue (USD) 2019-12-31
Period endedCost of RevenueChange YoYSource filing
2019-12-31$0-100.0%2020-02-27, From 2019-01-01
2018-12-31$597.5K-67.0%2020-02-27, From 2018-01-01
2017-12-31$1.81M+4.7%2019-03-06, From 2017-01-01
2016-12-31$1.73M+175.0%2018-02-26, From 2016-01-01
2015-12-31$629.2Kn/m2017-03-15, From 2015-01-01
2014-12-31$15.4Kn/a2017-03-15, From 2014-01-01